Access to Medicine Foundation
Emma Shiffman currently serves as a Research Coordinator and Researcher at Access to Medicine Foundation since July 2021. Prior experience includes roles as a Research Assistant in the HELIUS study at Amsterdam UMC from November 2020 to June 2021, and as a Student Assistant at Utrecht Centre for Affordable Biotherapeutics from October 2019 to October 2020. Emma also worked as a Communications Advisor at Health Action International from August 2018 to August 2019, and served as a Student Ambassador at University College Roosevelt from September 2016 to June 2018. Additional experience includes a Research Assistant position at Erasmus MC from June 2016 to December 2017. Emma holds a Master of Science in Epidemiology from Utrecht University and a Bachelor of Science in Cognitive Science, Life Science, and Biomedical Science from University College Roosevelt, along with an International Baccalaureate from Tashkent International School.
This person is not in any teams
Access to Medicine Foundation
The Access to Medicine Foundation is an independent non-profit organisation based in the Netherlands. We seek to transform the healthcare ecosystem by motivating and mobilising companies to expand access to their essential healthcare products in low- and middle-income countries. Over the past two decades, we have demonstrated the power of data, collaboration and persuasion to trigger action by the pharmaceutical industry and scale up access to products. Our tried-and-tested approach involves defining the actions that healthcare companies should take, analysing what companies are actually doing, and promoting best practices. To turn our insights into action, we engage with the companies we evaluate, as well as with stakeholders across the private and public sectors. Our power to make an impact has been proven in the case of Big Pharma, as demonstrated by the success of the Access to Medicine Index. We have now begun to further expand our scope and use our change-making model to move companies across a wider range of healthcare sectors. This encompasses core groups of companies across five sectors: Big Pharma, vaccine manufacturers, generic medicine manufacturers, diagnostic companies and medical gas companies. Learn more about how we are taking access to the next level 👉 accesstomedicinefoundation.org/news/taking-access-to-the-next-level-mobilising-five-essential-healthcare-sectors